Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group CEC.2 -- A Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p and 19q Codeleted Anaplastic Glioma -- was activated 28 July 2010.

http://www.ctg.queensu.ca/trials/brain/cec2/cec2.html